Laddar...
Next generation sequencing identifies ‘interactome’ signatures in relapsed and refractory metastatic colorectal cancer
BACKGROUND: In the management of metastatic colorectal cancer (mCRC), KRAS, NRAS and BRAF mutational status individualizes therapeutic options and identify a cohort of patients (pts) with an aggressive clinical course. We hypothesized that relapsed and refractory mCRC pts develop unique mutational s...
Sparad:
| I publikationen: | J Gastrointest Oncol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
AME Publishing Company
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5334057/ https://ncbi.nlm.nih.gov/pubmed/28280605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.09.05 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|